Vertex Pharmaceuticals Stock Forecast

Stock Price Forecast

The 22 analysts with 12-month price forecasts for VRTX stock have an average target of 459.59, with a low estimate of 370 and a high estimate of 559. The average target predicts a decrease of -6.51% from the current stock price of 491.57.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$370	$459.59	$456	$559
Change	-24.73%	-6.51%	-7.24%	+13.72%

Analyst Ratings

The average analyst rating for VRTX stock from 26 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Feb '24	Mar '24	Apr '24	May '24	Jun '24	Jul '24
Strong Buy	8	8	7	6	8	8
Buy	11	11	12	11	11	11
Hold	7	7	6	6	6	6
Sell	0	0	0	0	0	0
Strong Sell	1	1	1	1	1	1
Total	27	27	26	24	26	26

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Matthew Harrison Morgan Stanley	Morgan Stanley	Hold Maintains $402 → $455	Hold	Maintains	$402 → $455	-7.44%	Jul 11, 2024
Steve Chesney Redburn Atlantic	Redburn Atlantic	Strong Buy Initiates $545	Strong Buy	Initiates	$545	+10.87%	Jun 27, 2024
Mohit Bansal Wells Fargo	Wells Fargo	Buy Maintains $540 → $555	Buy	Maintains	$540 → $555	+12.90%	Jun 24, 2024
Jasper Hellweg Argus Research	Argus Research	Strong Buy Maintains $465 → $550	Strong Buy	Maintains	$465 → $550	+11.89%	Jun 17, 2024
Brian Abrahams RBC Capital	RBC Capital	Hold Maintains $424 → $421	Hold	Maintains	$424 → $421	-14.36%	Jun 11, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

10.97B

from 9.87B

11.14%

from 9.87B

Revenue Next Year

11.92B

from 10.97B

8.71%

from 10.97B

EPS This Year

17.43

from 13.89

25.47%

from 13.89

EPS Next Year

18.46

from 17.43

5.93%

from 17.43

Year	2019	2020	2021	2022	2023	2024	2025	2026	2027	2028
Revenue	4.16B	6.21B	7.57B	8.93B	9.87B	10.97B	11.92B	13.11B	14.35B	15.83B
Revenue Growth	36.59%	49.08%	22.06%	17.91%	10.51%	11.14%	8.71%	9.98%	9.42%	10.34%
EPS	4.51	10.29	9.01	12.82	13.89	17.43	18.46	21.10	22.54	25.35
EPS Growth	-44.25%	128.16%	-12.44%	42.29%	8.35%	25.47%	5.93%	14.29%	6.81%	12.50%
Forward PE	-	-	-	-	-	28.21	26.63	23.30	21.81	19.39
No. Analysts	-	-	-	-	-	34	33	24	14	14

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2024	2025	2026	2027	2028
High	11.5B	13.8B	15.2B	16.8B	19.1B
Avg	11.0B	11.9B	13.1B	14.3B	15.8B
Low	10.3B	10.8B	11.5B	11.6B	12.4B

Revenue Growth

Revenue Growth	2024	2025	2026	2027	2028
High	16.9%	25.5%	27.6%	27.8%	33.0%
Avg	11.1%	8.7%	10.0%	9.4%	10.3%
Low	4.7%	-1.4%	-3.2%	-11.7%	-13.4%

EPS Forecast

EPS	2024	2025	2026	2027	2028
High	19.29	23.59	29.86	27.95	32.07
Avg	17.43	18.46	21.10	22.54	25.35
Low	15.44	15.13	16.73	17.90	19.47

EPS Growth

EPS Growth	2024	2025	2026	2027	2028
High	38.9%	35.4%	61.7%	32.5%	42.3%
Avg	25.5%	5.9%	14.3%	6.8%	12.5%
Low	11.2%	-13.2%	-9.4%	-15.1%	-13.6%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.